简介:Epstein-Barr病毒(EBV),潜在的oncogenicherpesvirus,被发现了与几被联系malignancies.It是批评的得到身体的细胞的免疫与树枝状的房间(DC)与潜伏的膜蛋白质2A(LMP2A)装载了对肿瘤得到T房间反应的联系EBV的肿瘤development.Using斗争可以是最直接、最安全的免疫疗法approaches.The之一试图开发基于DCs的癌症疫苗(与LMP2A蛋白质装载的DC)的现在的学习和学习它的生物
简介:NanocrystallineanataseTiO2filmswithindiumtinoxide(ITO)coatedglassasthefilmsubstratewerefabricatedthroughspin-coatingtechnique.TheTiO2pasteswerepreparedwithsodiumdodecylbenzenesulfonate(DBS)modifiedTiO2nanocrystals,synthesizedbysol-hydrothermalprocessesinadvance,togetherwithdifferentamountsofpolyethyleneglycol(PEG)macromolecules.Theas-preparedfilmsweremainlycharacterizedbyultraviolet-visible(UV-Vis)spectroscopy,fieldemissionscanningelectronmicroscopy(FE-SEM)andwatercontactangle(WCA)measurement.EffectsoftheadditionofDBSandPEGonthewettingperformanceoftheresultingfilmsandrelevantmechanismswereprincipallyinvestigated.Theresultsshowthattheas-preparedfilmdisplayssuper-hydrophilicpropertyafterco-additionofDBSandPEGalthoughitisnotexposedtoultravioletlightpriortotheWCAmeasurement.Thisappealingresultismainlyattributedtotheproducedmicroandnanometer-scalehierarchicalsurfacestructurewithuniformlydispersedmicropapillae.EachpapillawasmadeupofagreatnumberofTiO2nanoparticles.ThepossibleformationmechanismsrelatedtotheDBSamphiphilicpropertyofthecharacteristicsurfacewerealsosuggested.Moreover,theresultingfilmalsoexhibitsconsiderabledurabilityinthesuperhydrophilicity,whichisveryusefulforpracticalapplicationinself-cleaning,anti-fogging,andbacteria-resistantfields.
简介:摘要多发性内分泌腺瘤2型是国内的一种内分泌系统疾病,在国内报道尚少,发病率低,但是一旦发生往往恶性程度较高。国外相关研究较多,国内医师对于此种疾病的鉴别及相关治疗认识尚未完全清晰,本文根据相关研究进展对多发性内分泌腺瘤进行了综述,对疾病相关的诊断、治疗等进行了阐述,提高临床工作者对于其认识。
简介:AIM:Toevaluatetheimpactofsociodemographic/clinicalfactorsonearlyvirologicalresponse(EVR)topegin-terferon/ribavirinforchronichepatitisC(CHC)inclinicalpractice.METHODS:Weconductedamulticenter,cross-sectional,observationalstudyinHepatologyUnitsof91Spanishhospitals.CHCpatientstreatedwithpeginterferonα-2aplusribavirinwereincluded.EVRwasdefinedasundetectablehepatitisCvirus(HCV)-ribonucleicacid(RNA)or≥2logHCV-RNAdecreaseafter12wkoftreatment.AbivariateanalysisofsociodemographicandclinicalvariablesassociatedwithEVRwascarriedout.IndependentfactorsassociatedwithanEVRwereanalyzedusingamultipleregressionanalysisthatincludedthefollowingbaselinedemographicandclinicalvariables:age(≤40yearsvs>40years),gender,race,educationallevel,maritalstatusandfamilystatus,weight,alcoholandtobaccoconsumption,sourceofHCVinfection,alanineaminotransferase(ALT)andaspartateaminotransferase(AST)levels,andgammaglutamyltranspeptidase(GGT)(≤85IU/mLvs>85IU/mL),serumferritin,serumHCV-RNAconcentration(<400000vs≥400000),genotype(1/4vs3/4),cirrhoticstatusandribavirindose(800/1000/1200mg/d).RESULTS:Atotalof1014patientswereincludedinthestudy.Meanageofthepatientswas44.3±9.8years,70%weremale,and97%wereCaucasian.ThemainsourcesofHCVinfectionwereintravenousdrugabuse(25%)andbloodtransfusion(23%).SeventyeightpercentwereinfectedwithHCVgenotype1/4(68%hadgenotype1)and22%withgenotypes2/3.TheHCV-RNAlevelwas>400000IU/mLin74%ofpatients.ThemeanALTandASTlevelswere88.4±69.7IU/mLand73.9±64.4IU/mL,respectively,andmeanGGTlevelwas82±91.6IU/mL.Themeanferritinlevelwas266±284.8μg/L.Only6.2%ofpatientspresentedwithcirrhosis.Allpatientsreceived180mgofpeginterferonα-2a.Themostfrequentlyusedribavirindoseswere1000mg/d(41%)and1200mg/d(41%).Theplannedtreatm